AWARD
A -- Phase 2b efficacy study with CoviLiv a proprietary live attenuated virus COVID-19 vaccine
- Notice Date
- 9/28/2023 11:32:01 AM
- Notice Type
- Award Notice
- NAICS
- 541714
— Research and Development in Biotechnology (except Nanobiotechnology)
- Contracting Office
- ASPR OFFICE OF THE ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE Washington DC 20201 USA
- ZIP Code
- 20201
- Solicitation Number
- BARDABAA-18-100-SOL-00003
- Archive Date
- 10/12/2023
- Point of Contact
- Kathleen Sears, Phone: 2027447667
- E-Mail Address
-
kathleen.sears@hhs.gov
(kathleen.sears@hhs.gov)
- Award Number
- 75A50123C00048
- Award Date
- 09/27/2023
- Awardee
- CODAGENIX INC Farmingdale NY 11735 USA
- Award Amount
- 389449172.00
- Description
- This is a competitively awarded hybrid cost-share CPFF contract for a Phase 2b efficacy study with CoviLiv a proprietary live attenuated virus COVID-19 vaccine.� The government's cost-share amount is�$389,449,172.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/461101b60db7424eb0d5bead7efe2e3d/view)
- Place of Performance
- Address: Farmingdale, NY 11735, USA
- Zip Code: 11735
- Country: USA
- Zip Code: 11735
- Record
- SN06847400-F 20230930/230928230043 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |